Which groundbreaking medical product launch included the FDA's first-ever virtual advisory committee meeting due to COVID-19 restrictions?

The healthcare industry is constantly evolving with innovative medical products that transform patient care. The journey from laboratory development to market availability involves numerous regulatory hurdles and strategic considerations. This poll tests your knowledge about a significant medical product launch that changed treatment paradigms and set new standards in the pharmaceutical industry.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Pfizer-BioNTech COVID-19 vaccine (December 2020)
Biogen's Aduhelm for Alzheimer's disease (June 2021)
Novartis' Zolgensma gene therapy for spinal muscular atrophy (May 2019)
AstraZeneca's Tagrisso for early-stage lung cancer (December 2020)